High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
J Hepatol. 2020 Sep;73(3):705-708.
doi: 10.1016/j.jhep.2020.05.013.
Epub 2020 May 21.
1 Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.
2 Oxford Liver Unit, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
3 Department of Medicine, Section of Hepatology, Rush University Medical Center, Chicago, Illinois, USA.
4 Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
5 Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
6 Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Spain.
7 Barts Liver Centre, Barts Health NHS Trust & Barts & The London School of Medicine & Dentistry, Queen Mary University of London, UK.
8 Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
9 Sheila Sherlock Liver Unit, Royal Free Hospital, London, UK.
10 Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
11 Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
12 CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
13 Division of Gastroenterology, University of Washington, Seattle, WA, USA.
14 Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
15 Oxford Liver Unit, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK. Electronic address: Thomas.marjot@ndm.ox.ac.uk.